Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,321,454 papers from all fields of science
Search
Sign In
Create Free Account
alpha-CGRP
Known as:
alpha CGRP
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Calcitonin Gene-Related Peptide
beta-CGRP
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Loss of alpha CGRP reduces sound-evoked activity in the cochlear nerve.
S. Maison
,
R. Emeson
,
Joe C. Adams
,
A. Luebke
,
M. Liberman
Journal of Neurophysiology
2003
Corpus ID: 22106834
alpha-Calcitonin gene-related peptide (alphaCGRP) is one of several neurotransmitters immunolocalized in the unmyelinated…
Expand
1996
1996
Multiple receptors for calcitonin gene‐related peptide and amylin on guinea‐pig ileum and vas deferens
A. Tomlinson
,
D. Poyner
British Journal of Pharmacology
1996
Corpus ID: 21189112
1 The responses of the electrically stimulated guinea‐pig ileum and vas deferens to human and rat calcitonin gene‐related peptide…
Expand
1995
1995
Calcitonin gene-related peptide as an endogenous vasodilator: immunoblockade studies in vivo with an anti-calcitonin gene-related peptide monoclonal antibody and its Fab' fragment.
K. Tan
,
M. Brown
,
R. Hargreaves
,
S. Shepheard
,
D. Cook
,
R. Hill
Clinical science
1995
Corpus ID: 46552512
1. Calcitonin gene-related peptide (CGRP) is localized in perivascular sensory neurons and is a potent vasodilator. We…
Expand
1992
1992
CGRP antagonist activity of short C-terminal fragments of human alpha CGRP, CGRP(23-37) and CGRP(19-37).
P. Rovero
,
S. Giuliani
,
C. Maggi
Peptides
1992
Corpus ID: 23075226
The activity of short C-terminal fragments of human alpha calcitonin gene-related peptide (CGRP), CGRP(19-37), and CGRP(23-37…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE